Myeloma Patients Europe (MPE) is an umbrella organisation of myeloma patient groups and associations from across Europe.
Myeloma Patients Europe (MPE) is an umbrella organisation of myeloma patient groups and associations from across Europe. MPE was formed following the merger in 2011 of the European Myeloma Platform and Myeloma Euronet.
MPE is registered as a non-profit organisation (AISBL) under Belgian law and its headquarter is located in Brussels.
MPE has a number of broad aims including:
• Collaborating on projects to the benefit of the myeloma community
• Exchanging information and best practice
• Developing existing patient groups and encouraging and facilitating the setting up of new groups
• Helping to shape appropriate health- related policies and initiatives on a European and national level
• Ensuring patients across Europe receive timely access to new treatment
• Stimulating and promoting patient- centred research and clinical trials
• Developing a strong evidence base for the needs and wants of patients and their role in research
• Providing information, educational and outreach programmes to member groups
To meet its aims and in addition to its membership, MPE works directly with healthcare professionals, reimbursement authorities, regulators, politicians, pharmaceutical companies, the media and anyone involved in the ‘myeloma community’.
Voeg deze kaart toe aan uw website;
We gebruiken cookies en andere trackingtechnologieën om uw browse-ervaring op onze website te verbeteren, om u gepersonaliseerde inhoud en gerichte advertenties te laten zien, om ons websiteverkeer te analyseren en om te begrijpen waar onze bezoekers vandaan komen. Privacybeleid